| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 619 |
| 1 | INFLIXIMAB | 612 |
| 2 | TOCILIZUMAB | 612 |
| 3 | METHOTREXATE SODIUM | 609 |
| 4 | ETANERCEPT | 605 |
| 5 | ABATACEPT | 595 |
| 6 | SULFASALAZINE | 593 |
| 7 | ALENDRONATE SODIUM | 590 |
| 8 | RITUXIMAB | 588 |
| 9 | PREDNISONE | 583 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | GOLD | 162 | 0.0279 |
| 1 | GOLIMUMAB | 312 | 0.0248 |
| 2 | BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE | 14 | 0.0226 |
| 3 | CHLOROQUINE PHOSPHATE | 10 | 0.0152 |
| 4 | PRAMIPEXOLE DIHYDROCHLORIDE | 69 | 0.0142 |
| 5 | FEBUXOSTAT TABLETS 40 MG | 144 | 0.0138 |
| 6 | DIMENHYDRINATE | 147 | 0.0137 |
| 7 | FEBUXOSTAT | 165 | 0.0097 |
| 8 | ETELCALCETIDE | 27 | 0.0094 |
| 9 | AMMONIUM CHLORIDE | 2 | 0.0080 |
| # | Drug class | Count |
|---|---|---|
| 0 | Tumor Necrosis Factor Blocker [EPC] | 622 |
| 1 | Corticosteroid [EPC] | 613 |
| 2 | Interleukin-6 Receptor Antagonist [EPC] | 612 |
| 3 | Selective T Cell Costimulation Modulator [EPC] | 595 |
| 4 | Aminosalicylate [EPC] | 593 |
| 5 | CD20-directed Cytolytic Antibody [EPC] | 590 |
| 6 | Antirheumatic Agent [EPC] | 576 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 562 |
| 8 | Nonsteroidal Anti-inflammatory Drug [EPC] | 349 |
| 9 | Proton Pump Inhibitor [EPC] | 312 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Provitamin D2 Compound [EPC] | 201 | 0.0068 |
| 1 | Alkaloid [EPC] | 157 | 0.0059 |
| 2 | Aminosalicylate [EPC] | 593 | 0.0059 |
| 3 | Antirheumatic Agent [EPC] | 576 | 0.0054 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 612 | 0.0044 |
| 5 | Selective T Cell Costimulation Modulator [EPC] | 595 | 0.0043 |
| 6 | Interleukin-17A Antagonist [EPC] | 131 | 0.0035 |
| 7 | Vitamin D2 Analog [EPC] | 23 | 0.0032 |
| 8 | Parenteral Iron Replacement [EPC] | 43 | 0.0031 |
| 9 | Calcineurin Inhibitor Immunosuppressant [EPC] | 281 | 0.0022 |